Geert Maertens

10.5k citations

100 papers · 6.5k indexed · 3 hit papers · h-index 36

Impact in

Hepatology top 0.05%
- Hepatitis C virus research
- Liver Disease and Transplantation
Epidemiology top 0.2%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment

Papers in

Hepatology 72
- Hepatitis C virus research 72
- Liver Diseases and Immunity 8
Epidemiology 61
- Hepatitis B Virus Studies 48
- Liver Disease Diagnosis and Treatment 23

Co-authors: Lieven Stuyver Ann Wyseur Nikolai V. Naoumov Erik Depla Roger Williams Edward Gane Bernard Portmann Peter T. Donaldson
Journals: Journal of Hepatology (11 papers)Journal of Medical Virology (8 papers)Journal of Clinical Oncology (7 papers)Journal of Virology (6 papers)Hepatology (6 papers)
Partner nations: Belgium France Netherlands

In The Last Decade

Geert Maertens

97 papers receiving 6.3k citations

Hit Papers

align trajectories log scale

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C 2000 · 608 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2000 Nature Medicine
1996 New England Journal of Medicine
1993 Journal of General Virology

Peers

Countries citing papers authored by Geert Maertens

Since Specialization

Citations

This map shows the geographic impact of Geert Maertens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geert Maertens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geert Maertens more than expected).

Fields of papers citing papers by Geert Maertens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geert Maertens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geert Maertens. The network helps show where Geert Maertens may publish in the future.

Co-authors

The 25 scholars most cited alongside Geert Maertens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Geert Maertens Line = papers co-authored together Geert Maertens links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Detection of microsatellite instability (MSI) with a novel panel of biomarkers in gastric cancer samples Annals of Oncology ·Bram De Craene, Zhu Feng, Evelien Rondelez, L. Vandenbroeck, K. Peeters, Geert Maertens, Erwin Sablon, Tianxi Cai	2017	2
2	Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors Journal of Translational Medicine ·Max Schreuer, Geert Meersseman, Sari Van Den Herrewegen, Yanina Jansen, Inès Chevolet, Ambre Bott, Sofie Wilgenhof, Teofila Seremet, Bart Jacobs, Ronald Buyl, Geert Maertens, Bart Neyns	2016	116
3	Fully automated and sensitive detection of EGFR exon 18, 19, 20 and 21 mutational status in less than 2.5 hours from a single FFPE slice Annals of Oncology ·Martin Reijans, Geneviève Vandercruyssen, Inge Keuleers, C. Vandesteene, Ina Vandenbroucke, Geert Maertens, Erwin Sablon	2016	2
4	Comparison of Pathogen DNA Isolation Methods from Large Volumes of Whole Blood to Improve Molecular Diagnosis of Bloodstream Infections PLoS ONE ·Anne J. M. Loonen, Martine P. Bos, Bart Van Meerbergen, Sigi Neerken, Arnold Catsburg, Irene Dobbelaer, Roel Penterman, Geert Maertens, Paul van de Wiel, Paul H. M. Savelkoul, Adriaan J. C. van den Brule	2013	66
5	Immunogenicity and Tolerability of Intradermal Administration of an HCV E1-Based Vaccine Candidate in Healthy Volunteers and Patients with Resolved or Ongoing Chronic HCV Infection Human Vaccines ·Geert Leroux‐Roels, Arsène-Hélène Batens, Isabelle Desombere, Bart Van Den Steen, Christine Vander Stichele, Geert Maertens, Frank Hulstaert	2005	37
6	Improvement in liver histology after 3 years of E1 therapeutic vaccination in 23 patients with chronic hepatitis C Ghent University Academic Bibliography (Ghent University) ·Frederik Nevens, Yves Horsmans, Tania Roskams, Hans Van Vlierberghe, D. Sprengers, A. Elewaut, Valeer Desmet, Geert Leroux‐Roels, Annick De Brauwer, Erik Depla, Stéphanie Dincq, Christine Vander Stichele, Frank Hulstaert, Geert Maertens	2004	2
7	A Pilot Study of Therapeutic Vaccination With Envelope Protein E1 in 35 Patients With Chronic Hepatitis C Hepatology ·Frederik Nevens, Tania Roskams, Hans Van Vlierberghe, Yves Horsmans, D. Sprengers, A. Elewaut, V. Desmet, Geert Leroux–Roels, Emmanuel Quinaux, Erik Depla, Stéphanie Dincq, Christine Vander Stichele, Geert Maertens, Frank Hulstaert	2003	102
8	Hepatic immunohistochemical staining with a monoclonal antibody against HCV-E2 to evaluate antiviral therapy and reinfection of liver grafts in hepatitis C viral infection Journal of Hepatology ·Chris Verslype, Frederik Nevens, Nicoletta Sinelli, Carine Clarysse, Jacques Pirenne, E Depla, Geert Maertens, Jos van Pelt, Valeer Desmet, Johan Fevery, Tania Roskams	2003	23
9	A candidate therapeutic vaccine for chronic hepatitis C infection based on envelope 1 protein: Tolerability and immunogenicity in healthy adult volunteers Ghent University Academic Bibliography (Ghent University) ·Geert Leroux‐Roels, Erik Depla, Frank Hulstaert, Jonathan De Smedt, Isabelle Desombere, Geert Maertens	2001	5
10	Validation of immunohistochemical staining with the monoclonal antibody 17H10 in liver biopsies for the diagnosis of chronic hepatitis C Hepatology ·Chris Verslype, Frederik Nevens, E Depla, Geert Maertens, Jos van Pelt, Johan Fevery, Tania Roskams	2000	4
11	Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C Nature Medicine ·Akinobu Takaki, Manfred Wiese, Geert Maertens, Erik Depla, Ulrike Seifert, Anke Liebetrau, Jeffery L. Miller, M.P. Manns, Barbara Rehermann Hit paper breakdown →	2000	608
12	Characterization of small hepatitis B surface antigen epitopes involved in binding to human annexin V Journal of Viral Hepatitis ·Sandra De Meyer, Erik Depla, Geert Maertens, A. Soumillion, Sing Hiem Yap	1999	12
13	ANTIBODIES TO HEPATITIS C VIRUS ENVELOPE PROTEINS CORRELATE WITH HEPATITIS C VIRAEMIA AFTER LIVER TRANSPLANTATION Transplantation ·Edward Gane, Geert Maertens, Annemie Ducatteeuw, Keping Qian, Johnson Y.N. Lau, H Jones, Edward T. Davies, Nikolai V. Naoumov, Roger Williams	1999	17
14	Hepatitis G Virus: Prevalence and Sequence Analysis in Blood Donors of São Paulo, Brazil Vox Sanguinis ·Leda Bassit, Bernhard Kleter, Gabriela Ribeiro‐dos‐Santos, Geert Maertens, Éster Cerdeira Sabino, D.A.F. Chamone, Wim Quint, Amadeo S aacute ez-Alqu eacute zar	1998	31
15	Long-Term Outcome of Hepatitis C Infection after Liver Transplantation New England Journal of Medicine ·Edward Gane, Bernard Portmann, Nikolai V. Naoumov, Heather M. Smith, James A. Underhill, Peter T. Donaldson, Geert Maertens, Roger Williams Hit paper breakdown →	1996	798
16	Recombinant secreted haemagglutinin protects mice against a lethal challenge of influenza virus Vaccine ·Peter Vanlandschoot, Geert Maertens, Willy Min Jou, Walter Fiers	1993	19
17	Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay Journal of General Virology ·Lieven Stuyver, R. Rossau, Ann Wyseur, M. Duhamel, B. Vanderborght, H. Van Heuverswyn, Geert Maertens Hit paper breakdown →	1993	627
18	Analysis of the Putative E1 Envelope and NS4a Epitope Regions of HCV Type 3 Biochemical and Biophysical Research Communications ·Lieven Stuyver, W Van Arnhem, Ann Wyseur, Robert Deleys, Geert Maertens	1993	25
19	The expression of the neu oncogene product in breast lesions and in normal fetal and adult human tissues Histopathology ·C. R. De Potter, Sabine Van daele, Marc J. van de Vijver, C. Pauwels, Geert Maertens, J. De Boever, D Vandekerckhove, H. Roels	1989	93
20	High-level transient expression of influenza virus proteins from a series of SV40 late and early replacement vectors Gene ·Danny Huylebroeck, Geert Maertens, Martine Verhoeyen, Claude Lopez, Alex Raeymakers, Willy Min Jou, Walter Fiers	1988	46

About Geert Maertens

Geert Maertens is a scholar working on Hepatology, Epidemiology, Transplantation, Cancer Research and Virology, having authored 100 papers that have together received 6.5k indexed citations. Recurring topics across this work include Hepatitis C virus research (72 papers), Hepatitis B Virus Studies (48 papers), Liver Disease Diagnosis and Treatment (23 papers), Monoclonal and Polyclonal Antibodies Research (17 papers), Cancer Genomics and Diagnostics (16 papers), Systemic Lupus Erythematosus Research (13 papers), Colorectal Cancer Treatments and Studies (8 papers) and Liver Diseases and Immunity (8 papers). The work is most often cited by research in Hepatology (5.5k citations), Epidemiology (4.7k citations), Transplantation (213 citations), Virology (350 citations) and Rheumatology (475 citations). Geert Maertens has collaborated with scholars based in Belgium, France and Netherlands. Frequent co-authors include Lieven Stuyver, Ann Wyseur, Nikolai V. Naoumov, Erik Depla, Roger Williams, Edward Gane, Bernard Portmann, Peter T. Donaldson, Heather M. Smith and James A. Underhill. Their work appears in journals such as Journal of Hepatology, Journal of Medical Virology, Journal of Clinical Oncology, Journal of Virology and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact